Literature DB >> 23624269

Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells: a mechanism for uric acid-induced cardiovascular disease development.

Jung-Hyun Park1, Yoon Mi Jin, Soojin Hwang, Du-Hyong Cho, Duk-Hee Kang, Inho Jo.   

Abstract

The elevated level of uric acid in the body is associated with increased risk of cardiovascular diseases, which is mediated by endothelial dysfunction. However, its underlying mechanism is not fully understood, although dysregulation of endothelial nitric oxide (NO) production is likely to be involved. Using human umbilical vascular endothelial cells (HUVEC), we explored the molecular mechanism of uric acid on endothelial NO synthase (eNOS) activity and NO production. Although high dose of uric acid (12mg/dl for 24h treatment) significantly decreased eNOS activity and NO production, it did not alter eNOS expression and phosphorylations at eNOS-Ser(1177), eNOS-Thr(495) and eNOS-Ser(114). Under this condition, we also found no alterations in the dimerization and acetylation of eNOS, compared with the control. Furthermore, uric acid did not change the activity of arginase II, an enzyme degrading l-arginine, a substrate of eNOS, and intracellular level of calcium, a cofactor for eNOS activation. We also found that uric acid did not alter xanthine oxidase activity, suggesting no involvement of xanthine oxidase-derived O2(-) production in the observed inhibitory effects. In vitro and in cell coimmunoprecipitation studies, however, revealed that uric acid significantly decreased the interaction between eNOS and calmodulin (CaM), an eNOS activator, although it did not change the intracellular CaM level. Like in HUVEC, uric acid also decreased eNOS-CaM interaction in bovine aortic EC. Finally, uric acid attenuated ionomycin-induced increase in the interaction between eNOS and CaM. This study suggests firstly that uric acid decreased eNOS activity and NO production through reducing the binding between eNOS and CaM in EC. Our result may provide molecular mechanism by which uric acid induces endothelial dysfunction.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23624269     DOI: 10.1016/j.niox.2013.04.003

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  34 in total

1.  Uric Acid and Cardiovascular Events: A Mendelian Randomization Study.

Authors:  Marcus E Kleber; Graciela Delgado; Tanja B Grammer; Günther Silbernagel; Jie Huang; Bernhard K Krämer; Eberhard Ritz; Winfried März
Journal:  J Am Soc Nephrol       Date:  2015-03-18       Impact factor: 10.121

Review 2.  Arterial Stiffness in the Heart Disease of CKD.

Authors:  Luca Zanoli; Paolo Lentini; Marie Briet; Pietro Castellino; Andrew A House; Gerard M London; Lorenzo Malatino; Peter A McCullough; Dimitri P Mikhailidis; Pierre Boutouyrie
Journal:  J Am Soc Nephrol       Date:  2019-04-30       Impact factor: 10.121

Review 3.  Roles of hyperuricemia in metabolic syndrome and cardiac-kidney-vascular system diseases.

Authors:  Hongsha Wang; Haifeng Zhang; Lin Sun; Weiying Guo
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

4.  Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women.

Authors:  Megha Prasad; Eric L Matteson; Joerg Herrmann; Rajiv Gulati; Charanjit S Rihal; Lilach O Lerman; Amir Lerman
Journal:  Hypertension       Date:  2016-12-19       Impact factor: 10.190

5.  Nitric oxide donor [Ru(terpy)(bdq)NO]3+ induces uncoupling and phosphorylation of endothelial nitric oxide synthase promoting oxidant production.

Authors:  Simone R Potje; Zhenlong Chen; Suellen D'Arc S Oliveira; Lusiane M Bendhack; Roberto S da Silva; Marcelo G Bonini; Cristina Antoniali; Richard D Minshall
Journal:  Free Radic Biol Med       Date:  2017-09-09       Impact factor: 7.376

6.  Optimization of Microenvironments Inducing Differentiation of Tonsil-Derived Mesenchymal Stem Cells into Endothelial Cell-Like Cells.

Authors:  Se-Young Oh; Da Hyeon Choi; Yoon Mi Jin; Yeonsil Yu; Ha Yeong Kim; Gyungah Kim; Yoon Shin Park; Inho Jo
Journal:  Tissue Eng Regen Med       Date:  2019-10-30       Impact factor: 4.169

7.  The Green Tea Component (-)-Epigallocatechin-3-Gallate Sensitizes Primary Endothelial Cells to Arsenite-Induced Apoptosis by Decreasing c-Jun N-Terminal Kinase-Mediated Catalase Activity.

Authors:  Jee-Youn Kim; Ji-Young Choi; Hyeon-Ju Lee; Catherine Jeonghae Byun; Jung-Hyun Park; Jae Hoon Park; Ho-Seong Cho; Sung-Jin Cho; Sangmee Ahn Jo; Inho Jo
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

Review 8.  Hyperuricemia-induced endothelial insulin resistance: the nitric oxide connection.

Authors:  Zahra Bahadoran; Parvin Mirmiran; Khosrow Kashfi; Asghar Ghasemi
Journal:  Pflugers Arch       Date:  2021-07-27       Impact factor: 3.657

9.  Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.

Authors:  Lih Kuo; Travis W Hein
Journal:  Front Immunol       Date:  2013-08-19       Impact factor: 7.561

Review 10.  The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness.

Authors:  Annayya R Aroor; Vincent G Demarco; Guanghong Jia; Zhe Sun; Ravi Nistala; Gerald A Meininger; James R Sowers
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-29       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.